Let’s Connect
Have questions or need assistance? Our team is here to help. Learn more about how Ametris’s innovative solutions can support your research and patient care goals.
Same team. Same mission.
Greater impact.
Monday, June 30, 2025 @ 12 PM ET
Digital health technologies empower the much-needed transformation of
oncology drug development, enabling more effective trial designs that focus
on the patient.
Digital health technologies empower the much-needed transformation
of oncology drug development, enabling more effective trial designs
that focus on the patient.
Access therapeutic area-specific resources developed to support
study teams interested in how DHTs can enhance their clinical
development programs.
| February 10-12 | Pensacola Beach, FL | LEARN MORE
Clinically meaningful and patient-centric outcome measures are essential to advancing scientific research and drug development, but traditional assessments often fall short. Ametris provides wearable digital health technology (DHT), along with integrated scientific and operational support, to help clinical teams capture real-world data that accurately reflects patient functioning. Our solutions support every phase of the trial lifecycle—from data collection to evidence generation—accelerating digital adoption, advancing regulatory goals, and ultimately driving meaningful impact for patients around the world.
Ametris’ FDA-cleared, medical-grade wearable devices and trusted remote monitoring platform are designed and optimized for clinical trials and scientific research. These solutions empower researchers to collect, process, and manage high-quality, real-world data with confidence and precision.
Ametris delivers seamless operational support across every phase of the clinical trial lifecycle. From site training and logistics to data transfer, archiving, and real-time study monitoring, our team ensures smooth deployment, regulatory readiness, and consistent data across global trials.
More than a technology provider, Ametris is a scientific partner. Our world-class experts support endpoint design, algorithm validation, DHT data interpretation, and regulatory strategy, ensuring your trial design is not only innovative but also fit-for-purpose and submission-ready.
Our digital health technology solution gives researchers a powerful way to capture continuous, objective, real-world data, revealing how participants function in their daily lives. Using state-of-the-art, transparent algorithms, Ametris helps translate this data into clinically meaningful insights across a range of measurement domains.
Ametris is the only technology partner offering an end-to-end digital health technology (DHT) solution. It combines best-in-class, medical-grade wearable devices, a scalable remote monitoring platform powered by state-of-the-art algorithms, and full-service operational and scientific support. Our integrated approach ensures the successful collection of fit-for-purpose, patient-centered digital measures across every phase of the clinical trial lifecycle.
Years of Remote Data
Capture Expertise
Peer-Reviewed
Scientific Publications
Industry-Sponsored
Clinical Trials
Countries Across the Globe
Sensor-based digital health technologies (DHTs) have revolutionized the ability to remotely obtain and analyze clinically…
In December 2023, the FDA released its final guidance on the use of digital health technologies (DHTs) for remote data...
Neurological diseases are inherently complex, and drug development in neurology is notoriously challenging. The imprecision…
Have questions or need assistance? Our team is here to help. Learn more about how Ametris’s innovative solutions can support your research and patient care goals.